Laman UtamaOXB • LON
add
Oxford BioMedica plc
Tutup sebelumnya
GBX 410.00
Julat hari
GBX 389.00 - GBX 412.00
Julat tahun
GBX 167.00 - GBX 450.00
Permodalan pasaran
415.37J GBP
Bilangan Purata
118.62K
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
LON
Berita pasaran
Investopedia
2 jam lalu
S&P 500 Gains and Losses Today: Eli Lilly Stock Falls as Sales Outlook
Weakens
0.11%
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (GBP) | Jun 2024info | Perubahan T/T |
|---|---|---|
Hasil | 25.40J | 17.99% |
Perbelanjaan pengendalian | 24.35J | -33.45% |
Pendapatan bersih | -16.24J | 32.26% |
Margin untung bersih | -63.94 | 42.59% |
Pendapatan bagi setiap syer | — | — |
EBITDA | -11.12J | 38.86% |
Kadar cukai berkesan | -1.86% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (GBP) | Jun 2024info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 81.41J | -37.10% |
Jumlah aset | 244.97J | -38.92% |
Jumlah liabiliti | 173.75J | -14.37% |
Jumlah ekuiti | 71.22J | — |
Syer tertunggak | 105.30J | — |
Harga kepada buku | 6.51 | — |
Pulangan pada aset | -15.68% | — |
Pulangan pada modal | -21.16% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (GBP) | Jun 2024info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | -16.24J | 32.26% |
Tunai daripada operasi | -19.60J | -624.03% |
Tunai daripada pelaburan | 3.64J | 308.64% |
Tunai daripada pembiayaan | 4.89J | 241.93% |
Perubahan bersih dalam tunai | -11.15J | -88.17% |
Aliran tunai bebas | -7.49J | 34.31% |
Perihal
Oxford Biomedica is a gene and cell therapy company specialising in the development of gene-based medicines. It is listed on the London Stock Exchange. Wikipedia
Diasaskan
1995
Tapak web
Pekerja
834
